Investors Resurrect Fraud Suit Over Nixed Sanofi Drug
A federal judge has reinstated a putative class action alleging Sanofi-Aventis SA deceived investors about the blockbuster prospects of its weight loss drug Zimulti, which never made it to market in...To view the full article, register now.
Already a subscriber? Click here to view full article